Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.

Zhen-Hui LuChun-Li YangGai-Ge YangWen-Xu PanLi-Guang TianJin-Xin ZhengShan LvShao-Yan ZhangPei-Yong ZhengShun-Xian Zhang

Published in: Infectious diseases of poverty (2021)

This multicenter, parallel-group, randomized controlled, interventional, prospective trial was registered at the Chinese Clinical Trial Registry (ChiCTR2000033284) on 26th May 2020 (prospective registered).

Keyphrases

phase iii
double blind
clinical trial
phase ii
placebo controlled
pulmonary fibrosis
open label
study protocol
sars cov
randomized controlled trial
cross sectional
rare case